medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 614

<< Back Next >>

Rev Med Cos Cen 2015; 72 (614)

Cambios hormonales en el síndrome de ovario poliquístico

Williams JRA

Language: Spanish
References: 14
Page: 17-21
PDF size: 304.82 Kb.


ABSTRACT

Polycystic Ovarian Syndrome is a heterogeneous endocrine disorder in which various metabolic, sexual, and psychological factors influence. A multidimensional and individualized approach is required, involving the patient in the process, in order to make life style changes and to set up a suitable pharmacological treatment, according to their characteristics and needs.


REFERENCES

  1. Araki, t., & Elias, R. (2011). Achieving Succesfull Pregnancy in Women with Polycystic Ovary Syndrome. Endocrinology and metabolism clinics, 40, 865-894.

  2. Ashrafi, M., & Sheikhan, f. (2014). Gestational diabetes mellitus risk factors in women with polycystic Ovary Syndrome (PCOS). European Journal of Obstetrics & Gynecology and, 181, 195-199.

  3. Aubuchon, M., & Burney, r. (2012). Esterilidad y Tecnicas de Reproduccion Asistida. En J. Berek, Berek y Novak Ginecologia (15 ed., págs. 1152-1157). Philadelphia: Wolters kluwer Health, Lippincotr Williams & Wilkins.

  4. Celik, C., & tasdemir, n. (2014). Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary Syndrome: a controlled follow -up study. Fertility and Sterility, 101, 1123-1128.

  5. Daranteu, L., & Lefevre, P. (210). Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS? Annales d’ Endocrinologie, 71, 25-27.

  6. Fernandez, D., & Felipe, S. (2007). Uso de la Metformina en pacienes con el sindrome del ovario poliquistico. Acta Medica Costarricense, 140-146.

  7. Fritz, M.:. (2011). Chronic Anovulation and Polycystic Ovary Syndrome. En M. :. Fritz, Ginecologia Endocrinologica e infertilidad (Octava ed., págs. 501- 518). philadelphia: Wolters Kluwer, Lippincott Williams & wilkins.

  8. Misso, M., & Teede, H. (2012). Status of clomiphene citrate and metformin for infertility in PCOS. Trends in Endocrinology and Metabolism, 23, 533-433.

  9. Nandi, A., & Chen, z. (2014). Polycystic Ovary Syndrome. Endocrinology and Metaboolism Clinics of North America, 43, 123-147.

  10. Norman, R., & Dellawy, D. (2007). Polycystic ovary syndrome. Lancet, 370, 685-697.

  11. Peigne, M. (2014). Long Term Complications of polycystic Ovary Syndrome. Annales d’ Endocrinologie, 75, 194-199.

  12. Roland, A., & Moenter, S. (2014). Reproductive neuroendocrine dysfunction in polycystic ovary syndrome. Frontiers in Neuroendocrinology, 35, 494-511.

  13. Setji, T., & Brown, A. (2014). Polycystic Ovary Syndrome: Update on Diagnosis and treatment. The American Journal Of Medicine, 127, 912-919.

  14. Youngster, M., & Ward, V. (2014). Utility of ultrasound in the diagnosis of Polycystic ovary Syndrome in adolescents. Fertility and Sterility, 1-7.




2020     |     www.medigraphic.com